Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by bealerton May 13, 2024 1:39pm
101 Views
Post# 36037190

RE:RE:Morgan Stanley selling

RE:RE:Morgan Stanley sellingHow do you have proof of your statements, BurningMoney5?

Hopefully there is still a small rabbit hiding in the folds of the bag that he can pull out, or that an investment firm has a plan that will work.

It would be a shame to accept defeat at this point of a hopeful turnaround.

I'm not sure Howhee would be willing to give up that easy as it also involves the lab, etc in France, and Geraldine and all her efforts.

It is truly sad to see the Morgan Stanley person(s) selling at this level, which only breeds more despair in the rest of us blind souls, giving us a signal of defeat to play games with our minds.

Let's keep our chins up in spite of the gloomy outlook.

BeAlert, but be cautious. Nobody likes this game at all!  Sirona had ABSOLUTELY no plans to economize and conserve funds or have a contingency plan for this, they just went ahead and spent money like drunken sailors, thinking that whenever they blew the whistle, people would come running with wheel barrows full of fresh cash.  What a lousy business plan. Should have stuck to using the scalpel on the patients instead of the investors.

<< Previous
Bullboard Posts
Next >>